Stock screener
Find stocks by market cap, trend, P/E, dividend, insider purchases and more – one click on a popular screen or your own filters. Choose other groups such as crypto under “Group”. You decide for yourself whether and when to trade.
Automated chart analysis, not investment advice – the decision and the risk are yours. Risk notice and investment advice
My filters
Available from Watcher: up to 5 saved filters (€9.99 per month). Plans and pricing
| Symbol | Market cap Market capitalizationThe stock market value of a company: share price times the number of shares. On the chart page we use the diluted share count averaged over the last fiscal year.Example: Price €50, 200m shares → €10bn.More in the Academy: Lesson P/E and P/S | 200-day line 200-day lineThe average of the closing prices of the last 200 trading days. If the price is above it, the longer-term trend counts as up. The current rule does not require this – the page shows the bigger trend for information only via the weekly chart.Example: Close 105, 200-day line 98 → price above the line.More in the Academy: Lesson 200-day line | 50-day line | RSI RSI (Relative Strength Index)Compares smoothed gains and losses, mainly of the last roughly 14 candles, and converts the ratio to 0 to 100. Above 70 counts as overbought, below 30 as oversold.Example: Avg. gain 0.60, avg. loss 0.20 → RS 3 → RSI 75.More in the Academy: Lesson reading the RSI | 52 weeks | Volume | Dividend | Revenue ± RevenueEverything a company takes in over a period with its products and services – before costs are deducted.Example: Revenue €500m, costs €440m → profit €60m.More in the Academy: Lesson revenue, profit and margin | KGV P/E (price-to-earnings ratio)Share price divided by earnings per share. With a loss it gives no meaningful value.Example: Price €45, earnings per share €3 → P/E 15.More in the Academy: Lesson P/E and P/S | Features | Fundamentals Fundamentals traffic lights in the screenerThree lights from the fundamental analysis: growth (revenue per year), net margin and debt, each compared with the sector. Green = at least the sector median, yellow = below, red = weak, gray = no data. Only stocks with SEC data.Example: Revenue +12% per year, sector +8% → growth green.More in the Academy: Lesson revenue, profit and margin |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY Lilly (Eli) · Health Care | very large | above | above | neutral | near high | – | yes | +44.7% | over 25 | near all-time high | Growth: greenMargin: greenDebt: red |
| JNJ Johnson & Johnson · Health Care | very large | above | above | neutral | – | – | yes | +6.1% | 15–25 | at strong support | Growth: yellowMargin: greenDebt: green |
| ABBV AbbVie · Health Care | very large | above | above | neutral | near high | – | yes | +8.6% | over 25 | near all-time high | Growth: yellowMargin: yellowDebt: gray |
| UNH UnitedHealth Group · Health Care | very large | above | above | neutral | – | – | yes | +11.8% | over 25 | at strong support | Growth: greenMargin: yellowDebt: green |
| MRK Merck & Co. · Health Care | very large | above | below | neutral | – | – | yes | +1.3% | 15–25 | – | Growth: yellowMargin: greenDebt: yellow |
| TMO Thermo Fisher Scientific · Health Care | very large | above | above | neutral | near high | – | yes | +3.9% | over 25 | near all-time high | Growth: yellowMargin: greenDebt: yellow |
| AMGN Amgen · Health Care | very large | above | above | neutral | near high | – | yes | +10.0% | over 25 | near all-time high | Growth: yellowMargin: greenDebt: red |
| GILD Gilead Sciences · Health Care | large | above | above | neutral | near high | – | yes | +2.4% | 15–25 | near all-time high | Growth: yellowMargin: greenDebt: red |
| ABT Abbott Laboratories · Health Care | large | above | below | neutral | – | – | yes | +5.7% | over 25 | – | Growth: yellowMargin: greenDebt: green |
| PFE Pfizer · Health Care | large | above | above | neutral | near high | – | yes | −1.7% | 15–25 | – | Growth: greenMargin: yellowDebt: yellow |
| DHR Danaher Corporation · Health Care | large | above | above | neutral | near high | – | none | +2.9% | over 25 | – | Growth: yellowMargin: greenDebt: green |
| ISRG Intuitive Surgical · Health Care | large | above | above | overbought | – | – | none | +20.5% | over 25 | at strong support | Growth: greenMargin: greenDebt: gray |
| VRTX Vertex Pharmaceuticals · Health Care | large | above | below | neutral | – | – | none | +8.9% | over 25 | – | Growth: greenMargin: greenDebt: gray |
| BMY Bristol Myers Squibb · Health Care | large | above | below | neutral | – | – | yes | −0.2% | 15–25 | RSI rebounded | Growth: yellowMargin: greenDebt: red |
| MDT Medtronic · Health Care | large | above | above | neutral | – | – | yes | +8.4% | over 25 | – | Growth: yellowMargin: greenDebt: gray |
| CVS CVS Health · Health Care | large | above | above | neutral | – | – | yes | +7.9% | over 25 | – | Growth: greenMargin: yellowDebt: gray |
| SYK Stryker Corporation · Health Care | large | below | above | neutral | – | – | – | +11.2% | over 25 | – | Growth: greenMargin: greenDebt: green |
| MCK McKesson Corporation · Health Care | large | above | above | neutral | near high | – | yes | +12.4% | over 25 | near all-time high | Growth: greenMargin: yellowDebt: gray |
| HCA HCA Healthcare · Health Care | large | above | above | neutral | – | – | yes | +7.1% | 15–25 | – | Growth: greenMargin: yellowDebt: gray |
| ELV Elevance Health · Health Care | large | above | above | neutral | near high | – | – | +12.5% | 15–25 | at strong support | Growth: greenMargin: yellowDebt: yellow |
| REGN Regeneron Pharmaceuticals · Health Care | large | above | above | neutral | – | – | none | +1.0% | 15–25 | – | Growth: greenMargin: greenDebt: green |
| CI Cigna · Health Care | large | above | above | neutral | near high | – | yes | +11.2% | under 15 | Golden crossat strong support | Growth: greenMargin: yellowDebt: gray |
| MRNA Moderna · Health Care | large | above | above | neutral | – | – | none | −39.9% | Loss | – | Growth: greenMargin: redDebt: green |
| IBRX ImmunityBio · Health Care | medium | above | below | neutral | – | – | none | +668.3% | Loss | – | Growth: greenMargin: redDebt: gray |
| NVAX Novavax · Health Care | small | above | below | neutral | – | – | none | +64.7% | under 15 | – | Growth: greenMargin: greenDebt: gray |
| IOVA Iovance Biotherapeutics · Health Care | small | above | above | neutral | – | – | none | +60.6% | Loss | – | Growth: grayMargin: redDebt: gray |
No match on this page.
+ 361 more stocks from Watcher
Extended universe: the same analysis with buy zone and analysis chart, updated once a week (on Saturdays).
How to read the list: The metrics describe past performance – no forecast and no recommendation. Price change = change of the closing price over the period; 50/200-day line = average of the last 50 or 200 closing prices; RSI(14) below 30 means “oversold”, above 70 “overbought”; 52 weeks = distance to the highest price of the past year; volume = shares traded on the last trading day relative to the average of the 50 days before. Market cap, dividend and revenue growth come from SEC filings (US stocks only). Click a column header to sort. Features = what currently stands out for the symbol (golden cross, RSI rebound, all-time high, strong support, insider purchases, earnings); P/E = price divided by earnings per share.